{
  "@context": "http://id.who.int/icd/contexts/contextForLinearizationEntity.json",
  "@id": "http://id.who.int/icd/release/11/2024-01/mms/1078767412",
  "parent": [
    "http://id.who.int/icd/release/11/2024-01/mms/1222145690"
  ],
  "browserUrl": "https://icd.who.int/browse/2024-01/mms/en#1078767412",
  "code": "4A00.15",
  "source": "http://id.who.int/icd/entity/1078767412",
  "classKind": "category",
  "title": {
    "@language": "en",
    "@value": "Acquired angioedema"
  },
  "definition": {
    "@language": "en",
    "@value": "Acquired angioedema is clinically similar to hereditary angioedema and is not associated with urticaria. It may be associated with a lymphoproliferative disorder (type I) or may be an isolated phenomenon due to an autoantibody directed against C1 inhibitor (type II)."
  },
  "indexTerm": [
    {
      "label": {
        "@language": "en",
        "@value": "Acquired angioedema"
      }
    },
    {
      "label": {
        "@language": "en",
        "@value": "Acquired angioneurotic oedema"
      }
    },
    {
      "label": {
        "@language": "en",
        "@value": "AAE - [Acquired angioneurotic oedema]"
      }
    },
    {
      "label": {
        "@language": "en",
        "@value": "Acquired angioedema type I"
      },
      "foundationReference": "http://id.who.int/icd/entity/850631759"
    },
    {
      "label": {
        "@language": "en",
        "@value": "AAE - [Acquired angioedema type I]"
      },
      "foundationReference": "http://id.who.int/icd/entity/850631759"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Acquired angioedema type II"
      },
      "foundationReference": "http://id.who.int/icd/entity/1071705004"
    },
    {
      "label": {
        "@language": "en",
        "@value": "AAE-II - [Acquired angioedema type II]"
      },
      "foundationReference": "http://id.who.int/icd/entity/1071705004"
    }
  ]
}